<DOC>
	<DOCNO>NCT02367534</DOCNO>
	<brief_summary>Islet transplantation one effective promising option type 1 diabetes mellitus treatment1-4 . The liver primary target location infusion portal vein catheterization generally use . Percutaneous transjugular , percutaneous transhepatic , laparoscopically transmesenteric laparoscopically transumbilical approach often utilized access portal . Current islet infusion approach via portal vein liver various defect . Percutaneous trans-hepatic puncture risk possible severe hemorrhage portal thrombosis . The laparoscopic entry technique require long surgical duration increase rate catheterization failure . Moreover , catheter allow indwell subsequent infusion . In current study , investigator aim perform open surgery , catheterize umbilical vein infuse islet portal vein . The catheter indwell one month surgery . Therapeutic effect , surgical parameter complication observe evaluate feasibility safety .</brief_summary>
	<brief_title>Islet Transplantation Through Indwelling Catheter Umbilical Vein</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Male female patient age 18 60 year age . Ability provide write informed consent . Clinical history compatible type 1 diabetes ( T1DM ) define WHO guideline ( 2007 ) Diagnosis classification Diabetes Mellitus . manifest sign symptom severe enough incapacitating . Basal Cpeptide &lt; 0.5ng/mL patient poor diabetes control ( HbA1c &gt; 7 % &lt; 12 % ) progressive diabetic complication . age &lt; 18 year &gt; 60 year diabetic history &lt; 5 year BMI &gt; 27 body weight &gt; 80kg exogenous insulin requirement &gt; 1 unit/kg/day severe anemia ( male &lt; 8g/dl , female &lt; 7g/dl ) low white blood cell count ( &lt; 3000/dl ) liver dysfunction Symptomatic peptic ulcer disease Any malignancy Active infection include hepatitis B , hepatitis C , HIV , TB panel reactive antibody &gt; 20 % Any medical condition , opinion investigator , interfere safe completion trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>